Geron (GERN) Asset Utilization Ratio (2011 - 2026)

Geron's (GERN) quarterly Asset Utilization Ratio came in at 0.09 in Q1 2026, down 53.25% year-on-year from 0.2 in Q1 2025, and up 34.92% quarter-over-quarter from 0.07 in Q4 2025.

Geron (GERN) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Geron has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.09 for Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.09, down 53.25% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.09 (down 53.25% YoY), and the FY2025 annual result was 0.07, down 56.2% from the prior year.
  • Asset Utilization Ratio came in at 0.09 for Q1 2026 at Geron, up from 0.07 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.33 in Q3 2025 to a low of 0.0 in Q3 2023.
  • The 5-year median for Asset Utilization Ratio is 0.01 (2022), against an average of 0.08.
  • Across the five-year window, Asset Utilization Ratio sank 110.34% in 2023 and jumped 30906.46% in 2025, its largest moves.
  • Geron's Asset Utilization Ratio stood at 0.01 in 2022, then sank by 110.34% to 0.0 in 2023, then jumped by 21964.96% to 0.15 in 2024, then tumbled by 52.88% to 0.07 in 2025, then surged by 34.92% to 0.09 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.07 (Q4 2025), and 0.33 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 0.55
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 1,422.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 0.47
9 Abivax 91.71 Bn 91.71 Bn - -
10 Geron 729,618.77 729,618.77 - 0.09

Historic Data

Download Data
DateValue
Mar 31, 2026 0.09
Dec 31, 2025 0.07
Sep 30, 2025 0.33
Jun 30, 2025 0.29
Mar 31, 2025 0.20
Dec 31, 2024 0.15
Sep 30, 2024 0.07
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00